Serotonin receptor subtypes and neuropsychiatric diseases: focus on 5-HT1D and 5-HT3 receptor agents.
Peroutka
S J
SJ
Department of Neurology, Stanford University, California.
D000818:Animals; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D008958:Models, Molecular; D011985:Receptors, Serotonin / Q000145:classification* / Q000187:drug effects; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D018170:Sumatriptan; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D007211:Indoles; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D013449:Sulfonamides; D014662:Vasoconstrictor Agents; D018170:Sumatriptan